Latest Compliance News

Southern Cross Media Group has secured legal approval to acquire Seven West Media, marking a significant consolidation in Australia's media landscape. Seven West Media shares will be suspended as the scheme moves to implementation.

JAYRIDE Group has amended its quarterly cash flow report to correct classification errors, while outlining plans for a new SaaS platform rollout and potential capital raising to support operations.

Brightstar Resources has adjusted its November gold production at Laverton Mine down to 4,652 ounces due to processing inefficiencies but remains confident in restoring recovery rates above 90%.

Native Mineral Resources Holdings has locked in a $3 million convertible note raising from Lind Global Fund III LP, with the option to access up to $10 million. The funding aims to bolster working capital and support growth in the Charters Tower region.

Antilles Gold has received an interim distribution of A$3.25 million from the liquidation of a former subsidiary, directing these funds to support construction of its Nueva Sabana copper-gold mine in Cuba.

Dimerix secures FDA confirmation that proteinuria reduction is a valid primary endpoint for its Phase 3 ACTION3 trial, advancing its kidney disease drug DMX-200 closer to approval.

Beacon Minerals has agreed to sell its Mt Dimer tenements to Forrestania Resources for A$50,000, marking a strategic move to focus on core assets and reduce costs.

Triton Minerals Limited has formally retracted certain visual estimates of mineralisation from its recent market update, acknowledging non-compliance with ASX reporting standards and urging investors to disregard these figures.

ActivEX Limited has completed a $100,000 share placement with Business Victor Investments Limited, aiming to accelerate its exploration activities and strengthen working capital.

Corella Resources has completed the first tranche of a $1 million share placement, issuing over 142 million shares at $0.0035 each. The second tranche and attached options await shareholder approval in early 2026.

The FDA’s recent ruling classifying traditionally prepared kava beverages as food under U.S. law clears a major regulatory hurdle for The Calmer Co, accelerating its growth on Amazon and strengthening its U.S. expansion strategy.

Next Science Limited has applied for voluntary delisting from the ASX following the sale of nearly all its assets to OSARTIS GmbH. The company proposes a capital return to shareholders and intends to commence winding up after delisting.